Manufacturers of impotence pills are facing a new challenge in the form of a nasal spray that acts in just eight minutes. The Aspirair device is similar to an asthma inhaler, and administers ...

Australian pharmaceutical company LTR Pharma has begun recruiting subjects in a bioequivalence clinical study of SPONTAN, a quick-acting nasal spray designed to treat erectile dysfunction (ED).

Originally published as ASX Quarterly Health Wrap: Lift-off for ED nasal spray and record users for pregnancy-monitoring platform ...

The APS enables registered medical practitioners to prescribe Spontan to a broader class of patients with ED, streamlining ... Aptar Pharma's expertise in nasal spray technology.